A detailed history of Guggenheim Capital LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 22,805 shares of IDXX stock, worth $9.52 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
22,805
Previous 25,408 10.24%
Holding current value
$9.52 Million
Previous $12.4 Million 6.96%
% of portfolio
0.08%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$455.08 - $517.19 $1.18 Million - $1.35 Million
-2,603 Reduced 10.24%
22,805 $11.5 Million
Q2 2024

Aug 14, 2024

SELL
$468.04 - $548.53 $1.95 Million - $2.29 Million
-4,169 Reduced 14.1%
25,408 $12.4 Million
Q1 2024

May 14, 2024

BUY
$515.08 - $576.87 $511,989 - $573,408
994 Added 3.48%
29,577 $16 Million
Q4 2023

Feb 14, 2024

BUY
$391.37 - $557.56 $161,244 - $229,714
412 Added 1.46%
28,583 $15.9 Million
Q3 2023

Nov 14, 2023

BUY
$432.42 - $556.67 $2.18 Million - $2.81 Million
5,039 Added 21.78%
28,171 $12.3 Million
Q2 2023

Aug 11, 2023

BUY
$450.7 - $503.61 $1.04 Million - $1.16 Million
2,305 Added 11.07%
23,132 $11.6 Million
Q1 2023

May 10, 2023

SELL
$406.01 - $514.59 $224,929 - $285,082
-554 Reduced 2.59%
20,827 $10.4 Million
Q4 2022

Feb 14, 2023

BUY
$324.64 - $441.27 $87,652 - $119,142
270 Added 1.28%
21,381 $8.72 Million
Q3 2022

Nov 14, 2022

BUY
$325.8 - $407.78 $168,438 - $210,822
517 Added 2.51%
21,111 $6.88 Million
Q2 2022

Aug 15, 2022

SELL
$327.37 - $553.44 $903,213 - $1.53 Million
-2,759 Reduced 11.81%
20,594 $7.22 Million
Q1 2022

May 16, 2022

SELL
$466.52 - $631.01 $2.49 Million - $3.37 Million
-5,337 Reduced 18.6%
23,353 $12.8 Million
Q4 2021

Feb 14, 2022

SELL
$586.54 - $666.48 $165,404 - $187,947
-282 Reduced 0.97%
28,690 $18.9 Million
Q3 2021

Nov 15, 2021

SELL
$621.9 - $705.76 $700,259 - $794,685
-1,126 Reduced 3.74%
28,972 $18 Million
Q2 2021

Aug 13, 2021

BUY
$486.36 - $637.08 $1.92 Million - $2.51 Million
3,943 Added 15.08%
30,098 $19 Million
Q1 2021

May 13, 2021

SELL
$465.18 - $551.79 $1.59 Million - $1.89 Million
-3,422 Reduced 11.57%
26,155 $12.8 Million
Q4 2020

Feb 16, 2021

BUY
$383.85 - $499.87 $1.67 Million - $2.18 Million
4,352 Added 17.25%
29,577 $14.8 Million
Q3 2020

Nov 13, 2020

SELL
$334.54 - $406.31 $920,988 - $1.12 Million
-2,753 Reduced 9.84%
25,225 $9.92 Million
Q2 2020

Aug 14, 2020

BUY
$230.66 - $330.16 $1.4 Million - $2.01 Million
6,079 Added 27.76%
27,978 $9.24 Million
Q1 2020

Jun 02, 2020

SELL
$182.94 - $290.97 $1.26 Million - $2.01 Million
-6,901 Reduced 23.96%
21,899 $5.3 Million
Q4 2019

Feb 14, 2020

SELL
$248.66 - $285.01 $1.63 Million - $1.87 Million
-6,548 Reduced 18.52%
28,800 $7.52 Million
Q3 2019

Nov 14, 2019

BUY
$260.07 - $289.93 $2.61 Million - $2.91 Million
10,020 Added 39.56%
35,348 $9.61 Million
Q2 2019

Aug 14, 2019

SELL
$215.53 - $275.33 $384,721 - $491,464
-1,785 Reduced 6.58%
25,328 $6.97 Million
Q1 2019

May 15, 2019

SELL
$178.02 - $225.69 $1.58 Million - $2 Million
-8,869 Reduced 24.65%
27,113 $6.06 Million
Q4 2018

Feb 14, 2019

SELL
$176.18 - $248.92 $2.6 Million - $3.68 Million
-14,776 Reduced 29.11%
35,982 $6.69 Million
Q3 2018

Nov 14, 2018

BUY
$218.82 - $254.46 $3.26 Million - $3.79 Million
14,907 Added 41.58%
50,758 $12.7 Million
Q2 2018

Aug 14, 2018

SELL
$185.56 - $227.9 $57.9 Million - $71.1 Million
-312,188 Reduced 89.7%
35,851 $7.81 Million
Q1 2018

May 15, 2018

SELL
$157.81 - $204.73 $8.82 Million - $11.4 Million
-55,865 Reduced 13.83%
348,039 $66.6 Million
Q4 2017

Feb 14, 2018

SELL
$147.68 - $168.37 $16.2 Million - $18.4 Million
-109,396 Reduced 21.31%
403,904 $63.2 Million
Q3 2017

Nov 14, 2017

BUY
$150.32 - $166.46 $77.2 Million - $85.4 Million
513,300
513,300 $79.8 Million

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $34.7B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.